Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn’s disease in children

Keyphrases

• Crohn's Disease 100%
• Budesonide 100%
• Moderate Exacerbations 100%
• Prednisone 54%
• Remission 45%
• Moderate to Severe 36%
• Mesalamine 18%
• Non-responders 9%
• Antibiotics 9%
• Age-matched 9%
• Mild Disease 9%
• Pediatric Crohn's Disease Activity Index 9%
• Medical Therapy 9%
• First-line Therapy 9%
• Improvement Factor 9%
• Design Charts 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Crohn's Disease 100%
• Budesonide 100%
• Prednisone 54%
• Remission 45%
• Aminosalicylic Acid 18%
• Disease 9%
• Combination Therapy 9%
• Retrospective Study 9%
• Antibiotics 9%
• Isoniazid 9%
• Disease Activity 9%

Medicine and Dentistry

• Crohn's Disease 100%
• Budesonide 100%
• Prednisone 54%
• Mesalazine 18%
• Disease 9%
• Pediatrics 9%
• Antibiotics 9%
• Retrospective Study 9%
• Combination Therapy 9%
• Crohn's Disease Activity Index 9%
• Isoniazid 9%